The customer initially questioned quality control (qc) results when they received new reagent lot number 173121 for the hcys homocysteine enzymatic assay (hcys).The customer performed comparison tests using the new reagent lot and the old reagent lot with patient samples and no differences were observed.Afterwards, the customer began to use the new reagent lot.Over time, their qc results began to drift and the customer decided not to run hcys tests with reagent lot 173121 until they received new reagents.Around this time the customer received communication from the manufacturer about reagent lot 173121.Due to this communication, the customer reviewed the median of the patient results tested for hcys and noticed the median had dropped.The customer concluded that they may have released incorrect, low hcys results.The customer has contacted medical personnel and informed them that the actual hcys patient results may not be as low as the results indicate.No specific results were provided and no patient information was provided.The customer provided a median result from (b)(6) 2016 of 13.261 umol/l and a median result from (b)(6) 2016 of 9.652 umol/l.No adverse event occurred.The cobas 8000 c (701) module serial number was not provided.The customer has discarded the reagent.
|
An issue with reagent lot 173121 resulting in under recovery of quality control and patient sample results has been confirmed by the investigation.The hcys lot number in this case is not distributed in the united states, therefore, this issue does not affect customers in the united states.
|